Literature DB >> 12637566

Caldesmon inhibits Arp2/3-mediated actin nucleation.

Yoshihiko Yamakita1, Fumio Oosawa, Shigeko Yamashiro, Fumio Matsumura.   

Abstract

The Arp2/3 complex greatly accelerates actin polymerization, which is thought to play a major role in cell motility by inducing membrane protrusions including ruffling movements. Membrane ruffles contain a variety of actin-binding proteins, which would modulate Arp2/3-dependent actin polymerization. However, their exact roles in actin polymerization remain to be established. Because caldesmon is present in membrane ruffles, as well as in stress fibers, it may alter Arp2/3-mediated actin polymerization. We have found that caldesmon greatly retards Arp2/3-induced actin polymerization. Kinetic analyses have revealed that caldesmon inhibits the nucleation process, whereas it does not largely reduce elongation. Caldesmon is found to inhibit binding of Arp2/3 to F-actin, which apparently reduces the ability of F-actin as a secondary activator of Arp2/3-mediated nucleation. We also have found that the inhibition of the binding between actin and caldesmon either by Ca(2+)/calmodulin or by phosphorylation with cdc2 kinase reverses the inhibitory effect of caldesmon on Arp2/3-induced actin polymerization. Our results suggest that caldesmon may be a key protein that modulates membrane ruffling and that this may involve changes in caldesmon phosphorylation and/or intracellular calcium concentrations during signal transduction.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12637566     DOI: 10.1074/jbc.M208739200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

1.  Filamentous-actins in human hepatocarcinoma cells with CLSM.

Authors:  Xia Huo; Xi-Jin Xu; Yao-Wen Chen; Hai-Wei Yang; Zhong-Xian Piao
Journal:  World J Gastroenterol       Date:  2004-06-01       Impact factor: 5.742

Review 2.  p53 regulation of podosome formation and cellular invasion in vascular smooth muscle cells.

Authors:  Alan S Mak
Journal:  Cell Adh Migr       Date:  2011-03-01       Impact factor: 3.405

3.  Comprehensive Proteomic and Metabolomic Signatures of Nontypeable Haemophilus influenzae-Induced Acute Otitis Media Reveal Bacterial Aerobic Respiration in an Immunosuppressed Environment.

Authors:  Alistair Harrison; Laura G Dubois; Lisa St John-Williams; M Arthur Moseley; Rachael L Hardison; Derek R Heimlich; Alexander Stoddard; Joseph E Kerschner; Sheryl S Justice; J Will Thompson; Kevin M Mason
Journal:  Mol Cell Proteomics       Date:  2015-12-28       Impact factor: 5.911

4.  Differential effects of caldesmon on the intermediate conformational states of polymerizing actin.

Authors:  Renjian Huang; Zenon Grabarek; Chih-Lueh Albert Wang
Journal:  J Biol Chem       Date:  2009-11-04       Impact factor: 5.157

5.  The Structurally Plastic CH2 Domain Is Linked to Distinct Functions of Fimbrins/Plastins.

Authors:  Ruihui Zhang; Ming Chang; Meng Zhang; Youjun Wu; Xiaolu Qu; Shanjin Huang
Journal:  J Biol Chem       Date:  2016-06-03       Impact factor: 5.157

Review 6.  Diversification of caldesmon-linked actin cytoskeleton in cell motility.

Authors:  Taira Mayanagi; Kenji Sobue
Journal:  Cell Adh Migr       Date:  2011-03-01       Impact factor: 3.405

7.  Direct interaction between caldesmon and cortactin.

Authors:  Renjian Huang; Gong-Jie Cao; Hongqiu Guo; Jolanta Kordowska; C-L Albert Wang
Journal:  Arch Biochem Biophys       Date:  2006-08-23       Impact factor: 4.013

8.  Gadkin negatively regulates cell spreading and motility via sequestration of the actin-nucleating ARP2/3 complex.

Authors:  Tanja Maritzen; Tobias Zech; Michael R Schmidt; Eberhard Krause; Laura M Machesky; Volker Haucke
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-11       Impact factor: 11.205

Review 9.  Caldesmon as a therapeutic target for proliferative vascular diseases.

Authors:  Chi-Ming Hai
Journal:  Mini Rev Med Chem       Date:  2008-10       Impact factor: 3.862

Review 10.  Smooth muscle signalling pathways in health and disease.

Authors:  H R Kim; S Appel; S Vetterkind; S S Gangopadhyay; K G Morgan
Journal:  J Cell Mol Med       Date:  2008-12       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.